Where does Albany Molecular Research, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Albany Molecular Research, Inc. ranks #13,289 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Albany Molecular Research, Inc. hold?

Albany Molecular Research, Inc. holds 22 US utility patents granted between 2015 and 2021, spanning 6 technology areas.

What is Albany Molecular Research, Inc.'s Innovation Score?

Albany Molecular Research, Inc. has an Innovation Score of 33.3 out of 100 (44th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Albany Molecular Research, Inc. focus on?

Albany Molecular Research, Inc.'s top technology area is C07D (Heterocyclic Compounds) with 22 patents, ranking #404 of 3,165 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Albany Molecular Research, Inc.'s patent grant rate increasing or decreasing?

Albany Molecular Research, Inc.'s recent grant velocity is -84% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Albany Molecular Research, Inc.'s patents?

Albany Molecular Research, Inc.'s patents average 22.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Albany Molecular Research, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Albany Molecular Research, Inc.

USPTO PatentsView assignee record - 22 granted patents across 6 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Albany ranks #13,289 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 6 technology areas.

#13,289
of 49,997 US assignees by volume: 44th percentile
by Innovation Score (33.3/100): 22.9
avg claims per patent: -84%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13289 · US Corporation #13,289 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,289/49,997
PHOTO-FINISH ACell
CPC-NARROW C07D · 6 areas
INNOV-THIN 33.3/100
CLAIMS-DENSE 22.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -84% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ACell, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Albany’s 33.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (32%) Velocity 0.0 pts (0%) Breadth 8.7 pts (26%) Claim depth 13.8 pts (41%)

Qualcomm Incorporated · highest

85
Albany Molecular… · this assignee

33
3D Lighting… · lowest

7

What this shows Albany's Innovation Score is 33.3/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Albany?

Each dot is one of Albany’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Albany’s own 22.9 claims/patent is ABOVE the 16.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Albany vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Albany's grants concentrate

Albany Molecular Research, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2015 (11 grants) versus a trough of 1 in 2021. By volume, Albany sits between Acsuper Technologies Inc. and Amerlux, LLC.

Acsuper

22
Acell

22
ADC Therapeutics

22
Advanpack Solutio…

22
Alcresta Therapeu…

22
Alcyone Lifescien…

22
American Maid Pla…

22
Amerlux

22
Albany Molecular… ◀

22

What this shows Albany holds 22 patents at rank #13,281, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Albany

By rank, the assignees closest to #13,281 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Albany's primary technology class.

Albany's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Albany Molecular Research, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	50.0%
2016	5	22.7%
2017	3	13.6%
2020	2	9.1%
2021	1	4.5%

Which technologies does Albany Molecular Research, Inc. patent most?

C07D - Heterocyclic Compounds 22

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 18

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

C07C - Acyclic OR Carbocyclic Compounds 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Albany Molecular Research, Inc.'s patent record in context - here's where to go next.

Albany Molecular Research, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #13,289 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Albany Molecular Research, Inc. against Acsuper Technologies Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.